Clinical Trial Update: A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (SOLAIRIA-2) sponsored by Generate Biomedicines is evaluating GB-0895 as adjunctive therapy for adults and adolescents with severe unco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GB-0895 (GB-0895)

Snippet

Sponsor: Generate Biomedicines | Conditions: Severe Asthma | Phase 3 | Status: RECRUITING